ALX-0171 Safety Study in Adults With Hyperresponsive Airways
NCT01909843
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
24
Enrollment
INDUSTRY
Sponsor class
Conditions
Respiratory Syncytial Virus Infection
Interventions
BIOLOGICAL:
ALX-0171
Sponsor
Ablynx, a Sanofi company